killer1

The chart shows the growth of an initial investment of $10,000 in killer1, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is never rebalanced.

As of Apr 3, 2026, the killer1 returned -17.45% Year-To-Date and 34.59% of annualized return in the last 10 years.

Based on dividend-adjusted daily data since Feb 12, 2010, killer1's average daily return is +0.20%, while the average monthly return is +3.83%. At this rate, your investment would double in approximately 1.5 years.

Historically, 62% of months were positive and 38% were negative. The best month was Apr 2020 with a return of +45.9%, while the worst month was Mar 2020 at -38.9%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 4 months.

On a daily basis, killer1 closed higher 56% of trading days. The best single day was Apr 9, 2025 with a return of +34.7%, while the worst single day was Mar 16, 2020 at -34.5%.

killer1 has an annualized alpha of 9.26%, beta of 3.26, and R² of 0.89 versus S&P 500 Index. Calculated based on daily prices since February 12, 2010.

• This portfolio captured 531.82% of S&P 500 Index gains and 224.74% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• This portfolio generated an annualized alpha of 9.26% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.
• Beta of 3.26 means this portfolio moves significantly more than S&P 500 Index — expect amplified gains in rallies and amplified losses in downturns.

killer1 has a high expense ratio of 0.94%, indicating above-average management fees. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

killer1 ranks 19 for risk / return — in the bottom 19% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

killer1 Sharpe ratios as of Apr 3, 2026 (values are recalculated daily):

• 1-Year: 0.68
• 5-Year: 0.21
• 10-Year: 0.54
• All Time: 0.64

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.98 to 1.66, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of killer1 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

killer1 provided a 0.78% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the killer1. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the killer1 was 80.52%, occurring on Dec 28, 2022. Recovery took 486 trading sessions.

The current killer1 drawdown is 27.34%.

The chart below shows the rolling one-month volatility.